Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

NCT05115838 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Human Immunodeficiency Virus
HIV

Interventions

DRUG: Islatravir
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC